ROYAL BANK OF CANADA - ATYR PHARMA INC ownership

ATYR PHARMA INC's ticker is LIFE and the CUSIP is 002120103. A total of 33 filers reported holding ATYR PHARMA INC in Q3 2018. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
ROYAL BANK OF CANADA ownership history of ATYR PHARMA INC
ValueSharesWeighting
Q2 2019$017
-67.3%
0.00%
Q1 2019$0520.0%0.00%
Q4 2018$0520.0%0.00%
Q3 2018$052
+477.8%
0.00%
Q3 2017$09
+28.6%
0.00%
Q1 2017$0
-100.0%
7
-97.9%
0.00%
Q3 2015$3,000
-62.5%
331
-19.5%
0.00%
Q2 2015$8,0004110.00%
Other shareholders
ATYR PHARMA INC shareholders Q3 2018
NameSharesValueWeighting ↓
Polaris Venture Management Co. V, L.L.C. 1,827,992$18,755,00012.78%
EcoR1 Capital, LLC 840,462$8,623,0003.92%
Rock Springs Capital Management LP 388,996$3,991,0000.32%
SPHERA FUNDS MANAGEMENT LTD. 209,027$2,145,0000.27%
Baker Brothers Advisors 2,335,125$23,958,0000.22%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 461,530$4,735,0000.18%
TIVERTON ASSET MANAGEMENT LLC 472,236$4,845,0000.11%
RS INVESTMENT MANAGEMENT CO LLC 1,082,249$11,104,0000.10%
RIVERHEAD CAPITAL MANAGEMENT LLC 415,377$4,262,0000.07%
Magnetar Financial LLC 354,659$3,639,0000.05%
View complete list of ATYR PHARMA INC shareholders